Treatment of High-Risk Neuroblastoma

被引：11
|
作者：
Krystal, Julie [1 ]
Foster, Jennifer H. [2 ]
机构：
[1] Cohen Childrens Med Ctr, Zucker Hofstra Sch Med, Dept Pediat, New Hyde Pk, NY 11040 USA
[2] Texas Childrens Canc Ctr, Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA
来源：
CHILDREN-BASEL | 2023年 / 10卷 / 08期
关键词：
neuroblastoma; pediatric oncology; solid tumor; OPEN-LABEL; CLASSIFICATION-SYSTEM; PROGNOSTIC IMPACT; CHILDHOOD-CANCER; FREE SURVIVAL; LOCAL-CONTROL; COG A3973; PHASE-II; CHILDREN; CHEMOTHERAPY;
D O I：
10.3390/children10081302
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
High-risk neuroblastoma is a highly aggressive solid tumor that most commonly presents in early childhood. Advances in treatment through decades of clinical trials and research have led to improved outcomes. This review provides an overview of the current state of treatment for high-risk neuroblastoma.
引用
收藏
页数：11
相关论文
共 50 条
  • [31] Immunocombination therapy for high-risk neuroblastoma
    Kroesen, Michiel
    Lindau, Dennis
    Hoogerbrugge, Peter
    Adema, Gosse J.
    IMMUNOTHERAPY, 2012, 4 (02) : 163 - 174
  • [32] A Safer Regimen for High-Risk Neuroblastoma
    Felix, Carolyn A.
    PEDIATRIC BLOOD & CANCER, 2009, 53 (01) : 3 - 6
  • [33] The Role of Surgery in High-risk Neuroblastoma
    Ryan, Anne L.
    Akinkuotu, Adesola
    Pierro, Agostino
    Morgenstern, Daniel A.
    Irwin, Meredith S.
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2020, 42 (01) : 1 - 7
  • [34] Evolving treatments in high-risk neuroblastoma
    Kumar, Abhinav
    Rocke, John P. J.
    Kumar, B. Nirmal
    EXPERT OPINION ON ORPHAN DRUGS, 2020, 8 (12): : 497 - 506
  • [35] Outcome of children with high-risk neuroblastoma
    Fluchel, M
    Hawkins, DS
    Felgenhauer, J
    Douglas, JJ
    Sanders, JE
    Park, JR
    PEDIATRIC RESEARCH, 2003, 53 (04) : 300A - 301A
  • [36] The Influence of Sarcopenia on High-Risk Neuroblastoma
    Kawakubo, Naonori
    Kinoshita, Yoshiaki
    Souzaki, Ryota
    Koga, Yuhki
    Oba, Utako
    Ohga, Shouichi
    Taguchi, Tomoaki
    JOURNAL OF SURGICAL RESEARCH, 2019, 236 : 101 - 105
  • [37] The Influence of Sarcopenia on High-Risk Neuroblastoma
    Isiklar, Aysun Dauti
    Safer, Umut
    Safer, Vildan Binay
    JOURNAL OF SURGICAL RESEARCH, 2019, 239 : 173 - 173
  • [38] PROTEOMIC ANALYSIS OF HIGH-RISK NEUROBLASTOMA
    Ho, M.
    Chua, Y. W.
    Kam, S. Y.
    Loh, A. H. P.
    Chang, K. T. E.
    Chua, J. H. Y.
    Chen, Y.
    Soh, S. Y.
    Lai, S. H.
    Hennessy, T.
    Kon, O. L.
    PEDIATRIC BLOOD & CANCER, 2013, 60 : 117 - 118
  • [39] Molecular aberrations in non-high risk neuroblastoma progressing to high-risk neuroblastoma
    Bruinsma, R.
    Dierselhuis, M.
    de Leng, W.
    Kester, L.
    van Noesel, M.
    Tytgat, L.
    van de Ven, K.
    Wijnen, M.
    de Krijger, R.
    van der Steeg, L.
    VIRCHOWS ARCHIV, 2024, 485 : S324 - S324
  • [40] Isotretinoin-induced psychosis in a child on treatment for high-risk neuroblastoma
    Greenwell, Alyssa M. M.
    Gorsi, Hamza S. S.
    PEDIATRIC BLOOD & CANCER, 2023, 70 (04)
12345